All differences were not statistically significant, but showed a clear trend.
← all excerpts
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
1
—
—